Sandoz Recalls Losartan Potassium and Ezetimibe Prescription Drug Bottles due to Packaging Issues

 Sandoz Recalls Losartan Potassium and Ezetimibe Prescription Drug Bottles due to Packaging Issues

Sandoz Recalls Losartan Potassium and Ezetimibe Prescription Drug Bottles due to Packaging Issues

Shots:

  • Sandoz recalls ~636,000 of Losartan potassium and Ezetimibe prescription drug bottles due to failure to meet child-resistant closure requirements as required by the Poison Prevention Packaging Act, posing a poisoning risk if swallowed by children
  • The products affected by the recall has distributed by Sandoz in the US includes Ezetimibe in 10mg tablets in 30 and 90 count bottles with its affected NDC numbers are # 0781-5690-31 (30 tablets) and # 0781-5690-92 (90 tablets) and Losartan potassium in 50mg in 30 count bottles with NDC number # 0781-5701-31
  • The affected lot was sold at clinics & pharmacies from Jul’18 to Aug’19. Consumers or pharmacies can contact Sandoz at  www.us.sandoz.com or 1-800-525-8747  for a free replacement child-resistant bottle cap and can continue the medication, once the medication is secured

Click here to­ read full press release/ article | Ref: PRNewswire | Image: WUSA9

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post